Our COVID-19 ELISA test is a Lab based serology test. The test measures your body's immune response to the novel coronavirus SARS-COV-2 by detecting the presence of two antibodies, IgG and IgM, specific for epitopes from SARS-CoV-2. The presence of these antibodies indicates exposure to the virus.

Results are for the detection of IgG and IgM antibodies to SARS-CoV-2. The SARS-CoV-2 antibodies are generally detectable in serum specimens shortly after infection. Typical immune response to infection begins with an IgM response followed by an IgG response within 1-2 weeks. Positive IgM and/or IgG results are indicative of recent, current, or past infection with SARS-CoV-2, but do not rule out infection with other, possible cross-reactive agents. Laboratories within the United States and its territories are required to report all positive results to the appropriate public health authorities.

The tests are available to qualified healthcare practitioners today. Please fill out the application form above and we will be in touch with more information. Our partners are working with the FDA to establish guidelines that may allow for direct shipments and at-home testing to be approved for individuals, over the age of 18, who meet the required criteria.

The tests and validations have been submitted to the FDA under Emergency User Authorization (EUA). A secondary set of validations and FDA EUA submissions have been conducted using the underlying ELISA and a proprietary self-collection device. All tests are analyzed at a CLIA and CAP accredited, high complexity laboratory based in the US.

The test is designed to be administered by healthcare professionals in clinics, patients’ homes and other locations where testing is required. These measures have been implemented to follow CDC test ordering guidelines. Please complete the form above if you are interested in bulk ordering tests and administering them to your patients.

The tests that are primarily being conducted at hospitals and testing facilities test for the presence of the virus in your body, called PCR tests. Unlike these tests, our serology test measures the presence of the antibodies responsible for neutralizing the SARS-COV-2 coronavirus. These tests can indicate exposure to the virus for those who were asymptomatic or who previously had symptoms but did not get tested. The test is designed to be administered by healthcare professionals in clinics, patients’ homes and other locations where testing is required.

There are several differences to be aware of between antibody tests and RNA detection tests. Antibody tests can determine whether someone has previously been exposed to the virus and PCR tests can diagnose an infection in the early stages. A number of weeks after you have recovered from an infection, there will be no detectable viral RNA left in your samples and your PCR test will be negative. It won’t show whether you were previously exposed to the virus.

A potential aid package that could help make coronavirus testing free for many Americans was announced recently and has been gaining momentum through Congress. We have reached out to elected officials to see how we can be involved - we would love to provide this test for free! As it stands, we are pricing the test as low as possible while covering our costs.

While it is still not known whether exposure to the SARS-COV-2 coronavirus will render one immune to the virus indefinitely, it is believed to be the case. If you test positive for an antibody test, it will indicate that your body has developed antibodies to fight the virus and is likely able to ward off future infections.

Anyone that has been symptomatic and has not tested positive for the SARS-COV-2 coronavirus, anyone that has been in close contact with someone who has been exposed to the virus or tested positive for the virus, and anyone that is currently living in a hot zone such as New York City should get an antibody test.

The Choose Health Blog has an article about COVID-19 Antibody Testing with the latest research and answers to frequently asked questions from medical expert, Dr. Robyn Heister. And check out our U.S. COVID-19 Data Visualization from the New York Times Github-hosted coronavirus dataset, which tracks daily reports of the cumulative cases and fatalities in every county in the US.. The report’s data updates twice a day, at 10pm and 10am.